scispace - formally typeset
S

Sara A. Currie

Researcher at Merck & Co.

Publications -  13
Citations -  1798

Sara A. Currie is an academic researcher from Merck & Co.. The author has contributed to research in topics: Streptomyces & Antibacterial agent. The author has an hindex of 9, co-authored 13 publications receiving 1711 citations.

Papers
More filters
Journal ArticleDOI

Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation

TL;DR: The avermectins are a complex of chemically related agents which exhibit extraordinarily potent anthelmintic activity and are produced by a novel species of actinomycete, NRRL 8165, which is named Streptomyces avermitilis.
Journal ArticleDOI

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

TL;DR: A new beta-lactam antibiotic, named thienamycin, was discovered in culture broths of Streptomyces MA4297, and subsequently determined to be a hitherto unrecognized species, is designated StrePTomyces cattleya (NRRL 8057).
Journal ArticleDOI

Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including Streptomyces lactamdurans sp. n

TL;DR: A number of actinomycetes isolated from soil were found to produce one or more members of a new family of antibiotics, the cephamycins, which are structurally related to cephalosporin C.
Journal ArticleDOI

Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I: Production, taxonomy and antibacterial activity

TL;DR: Two novel macrocyclic polyene lactone phosphate esters were discovered in fermentation broths of each of two strains of Bacillus subtilis and each showed a broad spectrum of activity against aerobic and anaerobic bacteria.